Histopathological analyses revealed substantial improvements in steatosis, fibrosis, and inflammation in the MCD-daclatasvir group (Fig. 4C, D), accompanied by significantly lower serum ALT and AST levels (Fig. 4E). This evidence concerns the gene GPT and steatosis.